On March 25, 2010
Military Use of Antipsychotics Threatens New Headaches for AstraZeneca, J&J
AstraZeneca (AZ) and Johnson & Johnson (JNJ) can expect a fresh round of PR headaches from a brewing Senate inquiry into military personnel taking antipsychotic and antidepressant drugs for post-traumatic stress disorder associated with combat in Iraq and Afghanistan. There’s
…
0 Comments